[Resistance to antibiotics in Pseudomonas aeruginosa in Colombian hospitals]. / Pseudomonas aeruginosa resistente a antimicrobianos en hospitales colombianos.
Rev Chilena Infectol
; 30(6): 605-10, 2013 Dec.
Article
en Es
| MEDLINE
| ID: mdl-24522302
Pseudomonas aeruginosa infections cause high morbidity and mortality. We performed a descriptive analysis of the rates of antibiotic resistance in isolates of P. aeruginosa in 33 hospitals enrolled in a surveillance network in Colombia. The study was conducted between January 2005 and December 2009 .9905 isolates of P. aeruginosa were identified, (4.9% of all strains). In intensive care units (ICU) P. aeruginosa showed an overall resistance to aztreonam, cefepime , ceftazidime, imipenem, meropenem , and piperacillin / tazobactam of 31.8% , 23.9% , 24.8%, 22.5%, 20.3% and 22.3%, respectively. Resistance rates increased for piperacillin/tazobactam, cefepime, and imipenem; remained unchanged for meropenem; and decreased for aminoglycosides, quinolones and ceftazidime. Resistance to one, two and three or more families of antibiotics was found in 17%, 12.5%, and 32.1%, respectively. In samples collected from the wards, the resistance rate was lower but usually over 10%. Antibiotic resistance in P. aeruginosa isolates in hospitalized patients and particularly in those admitted to ICUs in Colombia is high.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Pseudomonas aeruginosa
/
Farmacorresistencia Bacteriana Múltiple
/
Antibacterianos
Tipo de estudio:
Clinical_trials
/
Observational_studies
Límite:
Humans
País/Región como asunto:
America do sul
/
Colombia
Idioma:
Es
Revista:
Rev Chilena Infectol
Año:
2013
Tipo del documento:
Article
Pais de publicación:
Chile